Showing posts with label EKB-569. Show all posts
Showing posts with label EKB-569. Show all posts
Monday, July 16, 2012
EKB-569, Pelitinib enhanced FASN expression in some pre invasive lesions of prostate, colon and cutaneous nevi
Erlotinib, Pelitinib and/or EGF was extra to the prime layer as described and plated onto abottom agar layer containing Dulbecco,s modified Eagle,s medium, ten% calf serum and .five% Choose Agar with every single cell line/drug mixture plated in triplicate. After a 2 week incubation time period, the number of colonies was determined EKB-569 from ten fields photographed at 4 for every cell line/drug combination.